24 February 2024>: Clinical Research
Performance of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) in Chinese Population with Primary Prevention Indications: A Prospective Observational Cohort Study
Yaodong Li 1AEF , Yangxin Chen 2BCD , Jingfeng Wang 2BCD , Jian Xu 3BCD , Ruogu Li 4BCD , Zhaohui Qiu 5BCD , Lingyun Jiang 6BCD , Farong Shen 7BCD , Shubin Jiang 8BCD , Bin Li 9BCD , Yingjie Chu 10BCD , Lang He 11BCD , Lijin Pu 12BCD , Xuebin Han 13BCD , Xianping Long 14BCD , Xiaolin Xue 15BCD , Jianhong Tao 16BCD , Yongquan Wu 17BCD , Tao Guo 18BCD , Yiqiang Yuan 19BCD , Xianqing Wang 20BCD , Jiang Wang 21BCD , Jing Xu 22BCD , Yujie Zhao 23BCD , Zhihui Zhang 24BCD , Wei Hua 25ABCD* , Yangang Su 26ABCD* , Baopeng Tang 27ABCDEFG*DOI: 10.12659/MSM.942747
Med Sci Monit 2024; 30:e942747
Table 1 Inclusion and exclusion criteria of SCOPE trial.
Inclusion vriteria | Exclusion vriteria |
---|---|